Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Bone, Exercise, Alendronate, and Caloric Restriction Trial

NCT05764733 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Bone, Exercise, Alendronate, and Caloric Restriction Trial
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 4
Overall status
Recruiting
Start date
June 8, 2023
Completion date
January 31, 2028
Enrollment
900 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss